Details of issuance or disposal
Monthly exercise status of the 12th Series Stock Acquisition Rights (with provisions for adjustment of the exercise price) issued through a third-party allotment
Shares delivered during the month: 4,506,000 shares (new shares: 4,506,000; transferred treasury shares: 0)
Exercise ratio subject to exercise restrictions: 31.50% (shares delivered: 4,506,000 / listed shares as of the payment date: 14,305,000)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 12th Series Stock Acquisition Rights (with provisions for adjustment of the exercise price) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month: 4,506,000 shares (new shares: 4,506,000; transferred treasury shares: 0) |
| Payment date | 7 August 2026 (at the time these Stock Acquisition Rights were issued) |
| Intended allottee | EVO FUND |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 31.50% (shares delivered: 4,506,000 / listed shares as of the payment date: 14,305,000) |
| Total number of issued shares | 14,779,000 shares (as of the end of the month preceding the month covered, including 198 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥104, ¥126, ¥116, ¥111, ¥109, ¥110 and ¥114. Details and floor of the adjustment provisions: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100,000 rights; exercised during the month: 45,060 rights; unexercised at the end of the preceding month: 95,260 rights; unexercised at month-end: 50,200 rights |
| Procedures under the Corporate Code of Conduct | Exemption from the application of restrictions on exercises exceeding the limit under the Tokyo Stock Exchange's provisions concerning exercise restrictions and the purchase agreement |
| Most recent equity financing | 7 August 2026: Issuance by third-party allotment of Series 12 Stock Acquisition Rights with exercise price adjustment provisions and Series 3 unsecured corporate bonds (privately placed bonds) (detailed amount: Not disclosed) |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in September 2026 of the Series 12 Stock Acquisition Rights allocated to EVO FUND. The company explained that exercises exceeding 10% of the number of listed shares as of the payment date were conducted during the month, based on a provision in the purchase agreement exempting the rights from the prohibition on exercises exceeding the applicable limit when the exercise price is at least the closing price on 22 July 2026.